243 related articles for article (PubMed ID: 11138408)
1. Immune mechanisms that regulate susceptibility to autoimmune type I diabetes.
Singh B; Delovitch TL
Clin Rev Allergy Immunol; 2000 Dec; 19(3):247-64. PubMed ID: 11138408
[No Abstract] [Full Text] [Related]
2. In vivo blockade of the Fas-Fas ligand pathway inhibits cyclophosphamide-induced diabetes in NOD mice.
Mahiou J; Walter U; Lepault F; Godeau F; Bach JF; Chatenoud L
J Autoimmun; 2001 Jun; 16(4):431-40. PubMed ID: 11437491
[TBL] [Abstract][Full Text] [Related]
3. [Molecular mechanisms of pancreatic beta-cell destruction in type 1 diabetes].
Isotani H; Hanafusa T
Nihon Rinsho; 2002 Jul; 60 Suppl 7():383-7. PubMed ID: 12238077
[No Abstract] [Full Text] [Related]
4. Comparing the relative role of perforin/granzyme versus Fas/Fas ligand cytotoxic pathways in CD8+ T cell-mediated insulin-dependent diabetes mellitus.
Kreuwel HT; Morgan DJ; Krahl T; Ko A; Sarvetnick N; Sherman LA
J Immunol; 1999 Oct; 163(8):4335-41. PubMed ID: 10510373
[TBL] [Abstract][Full Text] [Related]
5. Evidence that beta cell death in the nonobese diabetic mouse is Fas independent.
Thomas HE; Darwiche R; Corbett JA; Kay TW
J Immunol; 1999 Aug; 163(3):1562-9. PubMed ID: 10415060
[TBL] [Abstract][Full Text] [Related]
6. Fas and Fas ligand expression in inflamed islets in pancreas sections of patients with recent-onset Type I diabetes mellitus.
Moriwaki M; Itoh N; Miyagawa J; Yamamoto K; Imagawa A; Yamagata K; Iwahashi H; Nakajima H; Namba M; Nagata S; Hanafusa T; Matsuzawa Y
Diabetologia; 1999 Nov; 42(11):1332-40. PubMed ID: 10550417
[TBL] [Abstract][Full Text] [Related]
7. Role of regulatory T cells in the pathogenesis of autoimmune diabetes.
Arreaza GA; Sharif S; Cameron MJ; Chen W; Delovitch TL
Curr Dir Autoimmun; 2001; 4():308-32. PubMed ID: 11569408
[No Abstract] [Full Text] [Related]
8. Role of Fas-FasL in insulitis in nonobese diabetic mouse.
Cao JY; Wang H
Chin Med J (Engl); 2004 Apr; 117(4):615-7. PubMed ID: 15109461
[No Abstract] [Full Text] [Related]
9. Mechanisms of diabetic autoimmunity: I--the inductive interface between islets and the immune system at onset of inflammation.
Askenasy N
Immunol Res; 2016 Apr; 64(2):360-8. PubMed ID: 26639356
[TBL] [Abstract][Full Text] [Related]
10. The role of FAS/FASLig and apoptosis in beta-cell death in animal models: relevance for human IDDM.
Giordano C; Richiusa P; Sbriglia MS; Pizzolanti G
Diabetes Metab Rev; 1998 Jun; 14(2):194-5. PubMed ID: 9679678
[No Abstract] [Full Text] [Related]
11. Islet antigen-specific T cell clones in autoimmune diabetes: from mice to men.
Schloot NC; Roep BO
Diabetes Metab Rev; 1997 Sep; 13(3):127-38. PubMed ID: 9307886
[No Abstract] [Full Text] [Related]
12. Activation-induced cell death in T cells and autoimmunity.
Zhang J; Xu X; Liu Y
Cell Mol Immunol; 2004 Jun; 1(3):186-92. PubMed ID: 16219166
[TBL] [Abstract][Full Text] [Related]
13. beta-Cell death during progression to diabetes.
Mathis D; Vence L; Benoist C
Nature; 2001 Dec; 414(6865):792-8. PubMed ID: 11742411
[TBL] [Abstract][Full Text] [Related]
14. T-cell reactivity to beta-cell antigens in human insulin-dependent (type 1) diabetes mellitus. Implications for diagnosis and therapy.
Roep BO
Clin Rev Allergy Immunol; 2000 Dec; 19(3):265-75. PubMed ID: 11138409
[No Abstract] [Full Text] [Related]
15. Immune response to glutamic acid decarboxylase correlates with insulitis in non-obese diabetic mice.
Cooke A; Mandel TE
J Endocrinol Invest; 1994; 17(7):586-93. PubMed ID: 7829835
[No Abstract] [Full Text] [Related]
16. [The molecular genetic aspects of insulin-dependent diabetes mellitus].
Pankov IuA; Chekhranova MK; Butnev VIu
Probl Endokrinol (Mosk); 1990; 36(4):3-11. PubMed ID: 2235930
[No Abstract] [Full Text] [Related]
17. Human T-cell responses to islet cell antigens.
Sønderstrup G; Durinovich-Belló I
Curr Dir Autoimmun; 2001; 4():239-51. PubMed ID: 11569405
[No Abstract] [Full Text] [Related]
18. Fas ligand down-regulates cytokine-induced Fas receptor expression on insulinoma (NIT-1), but not islet cells, from autoimmune nonobese diabetic mice.
Augstein P; Heinke P; Salzsieder E; Berg S; Rettig R; Salzsieder C; Harrison LC
Endocrinology; 2004 Jun; 145(6):2747-52. PubMed ID: 15033908
[TBL] [Abstract][Full Text] [Related]
19. Immune evasion by tumours: involvement of the CD95 (APO-1/Fas) system and its clinical implications.
Strand S; Galle PR
Mol Med Today; 1998 Feb; 4(2):63-8. PubMed ID: 9547792
[TBL] [Abstract][Full Text] [Related]
20. Standardization of T-cell assays in Type I diabetes. Immunology of Diabetes Society T-cell Committee.
Roep BO
Diabetologia; 1999 May; 42(5):636-7. PubMed ID: 10333064
[No Abstract] [Full Text] [Related]
[Next] [New Search]
